Livagen

Product Name:

Livagen

Chemical Information:

• Molecular Formula: C₁₈H₃₁N₅O₉
• Molecular Weight: ~461.5 g/mol
• Sequence: H-Lys-Gly-Asp-Ala –OH
• Structure Class: Synthetic tetrapeptide stabilized with zinc

Molecular Structure:

↺ + − ⛶

Product Description:

Livagen is a synthetic tetrapeptide complex containing lysine, glycine, aspartic acid, and alanine, stabilized in the presence of zinc. It is provided in lyophilized powder form to ensure high purity and stability for laboratory use. Livagen is intended exclusively for in vitro studies by qualified research professionals investigating peptide–metal interactions and peptide-based research models.

Research Applications:

Livagen is utilized in controlled research protocols addressing topics such as:

• In vitro investigation of zinc–peptide complexes in signaling pathway models
• Laboratory analysis of short peptide interaction dynamics in controlled systems
• Evaluation of peptide stability in the presence of coordinated metal ions
• Comparative studies of tetrapeptides and their analogues under defined experimental conditions

Storage and Handling:

• Store lyophilized material at −20°C (−4°F)
• After reconstitution, store at 2–8°C (36–46°F) and use promptly
• Avoid repeated freeze-thaw cycles
• Maintain aseptic laboratory handling procedures

Product Specifications:

• Purity: ≥99% (HPLC Certified)
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in suitable laboratory agents

Compliance Notice:

Livagen is FOR RESEARCH USE ONLY. It is not intended for human or veterinary use. This product has not been evaluated by the FDA. Misuse of this product is strictly prohibited and may violate federal, state, or local laws. By purchasing this product, buyer represents and warrants that it will be used only for in vitro research purposes.